Popular Articles

Idaho Technology Gains Army Approval Of Platinum Path™ Extraction Kit For Biological Pathogen Detection Program
Idaho Technology, Inc. has received the support of the U.S. Army Test and Evaluation Command (ATEC) for use of the Platinum Path™ Extraction Kit (PPEK) with the Joint Biological Agent Identification and Diagnostic System (JBAIDS).

U.N. Allocates $6M Emergency Fund To Address Health Problems In Ethiopia
The U.N."s Central Emergency Response Fund (CERF) recently allocated $6 million to address several health challenges facing Ethiopia, IRIN reports. Fidele Sarassoro, the U.N. humanitarian coordinator, said the country is having difficulty meeting the population"s basic health needs. The federal Disaster Risk Management and Food Security Sector (DRMFSS) has announced that rising malnutrition and food insecurity are a "growing concern and likely to lead to 6.2 million Ethiopians relying on food aid, out of a population of approximately 77 million," IRIN writes, adding that currently 4.9 million people in the country receive food aid (7/27).
News of the day
Details Remain Unclear On Medicare Drug Deal
The White House formally announced the drug manufacturers" plan to lower Medicare drug prices Monday. While details still remain unclear, it appears drug companies may benefit from the deal.
Health Insurance

Multidisciplinary Cancer Congress

ECCO 15 - ESMO 34 will take place at the ICC Berlin - Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany (http://www.icc-berlin.de) from Sunday 20 September to Thursday 24 September 2009. ECCO 15 - ESMO 34 will build on the success of the previous ECCO (European Cancer Conference) and ESMO (European Society for Medical Oncology) conferences. It provides a unique European forum for presentations of cutting-edge research from experimental and clinical oncologists, epidemiologists and cancer nurses. Over 15,000 scientists, doctors, nurses, patients, carers and industry representatives are expected to attend. More than 100 experts in different cancer fields have developed a wide-ranging and exciting congress programme, with large numbers of reports of translational research and first reports from high quality phase III clinical trials. In addition, for the first time there will be an "oncopolicy" track; this has been introduced to help inform European policy on cancer and to ensure its place at the top of the EU health and research policy agenda. Mary Rice ECCO-the European CanCer Organisation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):